nandrolone has been researched along with Cardiovascular Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Börjesson, A; Choong, E; Ekström, L; Gårevik, N; Lehtihet, M | 1 |
| Dinger, J; Do Minh, T; Heinemann, K | 1 |
| Hartgens, F; Keizer, HA; Kuipers, H; Rietjens, G; Wolffenbuttel, BH | 1 |
| Aygun, E; Dansuk, R; Kucukercan, I; Pirimoglu, ZM; Turan, C; Unal, O | 1 |
| Cockcroft, J; Davies, JS; Grace, F; Lane, HA; Morris, K; Scanlon, MF; Smith, JC | 1 |
| Kuhl, H; Wiegratz, I | 1 |
| Bourgeois, MO; Bray, GA; Greeson, C; Lovejoy, JC; Macchiavelli, R; Partington, C; Rood, JC | 1 |
| Gräser, T; Lüdtke, R; Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Skouby, SO | 1 |
| Karbasnikova, GV; Leshchinskiĭ, LA; Vasil'kova, AA; Zabel'ian, OM | 1 |
| Segal', RG; Zharov, EI | 1 |
3 review(s) available for nandrolone and Cardiovascular Diseases
| Article | Year |
|---|---|
Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications?
Topics: Androgens; Aromatase; Breast Diseases; Cardiovascular Diseases; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemias; Liver; Nandrolone; Norethindrone; Norethynodrel; Norpregnenes; Uterine Diseases | 2007 |
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
[Use of anabolic hormones for the treatment of cardiovascular patients].
Topics: Anabolic Agents; Androgens; Animals; Anticholesteremic Agents; Butyrates; Cardiovascular Diseases; Coronary Disease; Coronary Vessels; Heart; Heart Conduction System; Heart Failure; Humans; Hypertension; Liver; Liver Diseases; Methandrostenolone; Methenolone; Methyltestosterone; Models, Chemical; Myocardial Infarction; Nandrolone; Norethandrolone; Propionates; Testosterone; Vasodilator Agents; Water-Electrolyte Balance | 1969 |
5 trial(s) available for nandrolone and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Topics: Adult; Anabolic Agents; Androgens; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Double-Blind Method; Exercise; Humans; Injections, Intramuscular; Lipoprotein(a); Male; Nandrolone; Nandrolone Decanoate; Prospective Studies; Self Administration; Triglycerides | 2004 |
The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Topics: Adult; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Nandrolone; Postmenopause; Treatment Outcome | 2005 |
Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study.
Topics: Adipose Tissue; Androgen Antagonists; Androgens; Body Composition; Cardiovascular Diseases; Female; Hormones; Humans; Nandrolone; Nandrolone Decanoate; Obesity; Postmenopause; Risk Factors; Spironolactone | 1996 |
Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest.
Topics: Administration, Oral; Atrial Natriuretic Factor; Biomarkers; Cardiovascular Diseases; Cyclic GMP; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nandrolone; Peptide Fragments; Postmenopause; Prospective Studies; Serotonin; Vasodilation | 2001 |
[Use of cardiac glycosides of strophanthin-like action in the pharmacotherapy of chronic circulatory insufficiency].
Topics: Adenosine Triphosphate; Adult; Aged; Cardiac Glycosides; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Female; Heart Failure; Humans; Lung Diseases; Male; Middle Aged; Nandrolone; Phenylpropionates; Plants, Medicinal; Plasma Substitutes; Rheumatic Heart Disease; Strophanthins; USSR | 1978 |
3 other study(ies) available for nandrolone and Cardiovascular Diseases
| Article | Year |
|---|---|
Impact of single-dose nandrolone decanoate on gonadotropins, blood lipids and HMG CoA reductase in healthy men.
Topics: Adult; Anabolic Agents; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Follicle Stimulating Hormone; Gonadotropins; Humans; Hydroxymethylglutaryl CoA Reductases; Lipids; Luteinizing Hormone; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Risk Factors; RNA, Messenger | 2016 |
Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Nandrolone; Patient Reported Outcome Measures; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; United States; Venous Thromboembolism; Young Adult | 2016 |
Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Topics: Administration, Sublingual; Adult; Anabolic Agents; Androgens; Blood Pressure; Cardiovascular Diseases; Doping in Sports; Endothelium, Vascular; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nandrolone; Nitroglycerin; Sports; Stanozolol; Testosterone; Vasodilation | 2006 |